National
Supreme Court set to hear oral arguments on marriage
Attorneys in Prop 8, DOMA cases prepare for next week’s showdown
All eyes will be on the Supreme Court next week when it hears arguments in the Prop 8 and DOMA cases. (Washington Blade photos by Michael Key)
At a time of intense national debate, the U.S. Supreme Court for the first time ever will hear oral arguments next week on whether marriage rights for gay couples are protected under the U.S. Constitution.
Attorneys on both sides will make their arguments in two separate cases, on two separate days and regarding two separate anti-gay measures, but the state of marriage equality across the country could be altered depending on the rulings in either of the cases.
On Tuesday, the court will hear arguments on Proposition 8, a ballot measure approved by California voters in 2008 that stripped away existing marriage rights in the state for same-sex couples. The next day, the court will listen to arguments on the federal Defense of Marriage Act, which prohibits federal recognition of same-sex marriage.
Chris Stoll, a senior staff attorney at the National Center for Lesbian Rights, said the oral arguments provide an opportunity for observers to glean what justices are thinking based on their line of questioning.
“It’s true that appellate courts, I would say, mostly base their decisions on the written submissions on the briefs,” Stoll said. “The main purpose of oral argument is to let the justices have questions that they have answered by the lawyers, and so, what the lawyers come in to say isn’t really the focus; it’s really what the justices want to have answered.”
Mary Bonauto, civil rights director for Gay & Lesbian Advocates & Defenders, said oral arguments are a “filtering process” that provide justices the opportunity to explore possible outcomes of their rulings and persuade each other.
“That’s part of why they’re so active,” Bonauto said. “They’re trying to influence each other’s votes and perspectives on it, and, effectively, argue the case themselves. If you ever read a Supreme Court transcript, it’s usually very difficult to read because there are so many interruptions.”
In the Prop 8 case, known as Hollingsworth v. Perry, Ted Olson, a former solicitor general under President George W. Bush, will argue against the constitutionality of the measure on behalf of the American Foundation for Equal Rights. Based on the legal brief he filed, Olson will likely argue against the merits of Prop 8 on the basis that it violates due process and equal protection of gay plaintiff couples under the U.S. Constitution.
The ban on same-sex marriage will be defended by anti-gay groups, such as ProtectMarriage.com, because California state officials have declined to defend the marriage ban. The lawyer arguing on behalf of the anti-gay measure will likely be private attorney Charles Cooper, who defended Prop 8 during the district court trial in 2010.
Depending on the scope, a ruling in the Prop 8 case in favor of the plaintiffs could be a jackpot for same-sex couples. Justices could affirm the limited ruling from the U.S. Ninth Circuit Court of Appeals, which affected only California; determine that the nine states, including California, that offer domestic partnerships must offer same-sex marriage; or issue a sweeping ruling that brings marriage equality to all 50 states.
In the DOMA case, known as Windsor v. United States, Roberta Kaplan, a New York-based attorney, is set to argue against the constitutionality of the anti-gay law in a coordinated effort with the American Civil Liberties Union. Kaplan’s client is Edith Windsor, an 83-year-old lesbian who was forced to pay $363,000 in estate taxes upon the death in 2009 of her spouse, Thea Spyer, because of DOMA.
James Esseks, director of the ACLU’s LGBT Project, said preparations have been underway for oral arguments, including moot courts where individuals impersonate justices to ask possible questions that the real ones may pose.
“People do that for Supreme Court arguments, people do that for appeals court arguments, people do that for trial court arguments — we’ve done that all along,” Esseks said. “It’s just the normal thing that people do.”
On the other side of the DOMA case will be Paul Clement, another former U.S. solicitor general from the Bush administration. He was hired at a rate of $520 an hour by the House Republican-led Bipartisan Legal Advisory Group to defend DOMA in court.
The stakes in the DOMA case are high as well. A ruling striking down DOMA would have multiple impacts on married gay couples. Among other things, they’d have access to medical leave if their spouses need attention because they’re gravely ill or injured and Social Security survivor benefits would become available.
A ruling that strikes down DOMA would also remove a barrier for gay service members seeking spousal benefits in the wake of “Don’t Ask, Don’t Tell” repeal. According to a report published last month from the Center for American Progress and OutServe-SLDN, the average gay military family pays $5,615 out-of-pocket each year for health care insurance because they aren’t eligible for military coverage known as TRICARE.
Both oral arguments will share a common participant: U.S. Solicitor General Donald Verrilli. Since the Obama administration stopped defending DOMA in court, it has participated in litigation against DOMA and will have speaking time in arguments before the Supreme Court. Similarly, in the wake of filing a friend-of-the-court brief against Prop 8, the Justice Department will also have speaking time to argue against it thanks to a request.
In either or both cases, the Supreme Court could determine as part of its ruling that laws related to sexual orientation should be subject to heightened scrutiny, or a greater assumption they’re unconstitutional. That’s the view the Justice Department has articulated in legal briefs against DOMA and Prop 8.
Such a decision would also have a sweeping impact because it would create a precedent that guides other courts when evaluating the constitutionality of anti-gay laws, such as bans on same-sex marriage.
But the merits issue — the question of whether Prop 8 and DOMA are constitutional — will only form part of the discussion in the cases as other issues such as standing and jurisdiction must be addressed. These issues may ultimately form the basis of the court’s rulings.
In the Prop 8 case, the question is whether proponents of the measure have standing to defend the measure in court. It’s possible — as Olson and his team have argued — the court would rule they lack standing because they aren’t harmed by Prop 8. Such a ruling would leave unanswered questions about the constitutionality of same-sex marriage in California, but likely restore same-sex marriage in that state.
The questions about standing and jurisdiction in the DOMA case are more complex. The court asked attorneys when taking up the case whether BLAG has standing to participate and whether the Obama administration’s agreement with lower courts that DOMA is unconstitutional deprives the Supreme Court of jurisdiction. It’s unclear what the fate of DOMA would be if the court decides to rule on those grounds.
GLAD’s Bonauto said she thinks the stronger argument is the court has jurisdiction to consider DOMA and will decide on the merits — but noted “they asked the question for a reason” and questions emerge if the court decides to rule on DOMA on the basis of standing.
“Most people think the Second Circuit decision goes away, then the question is what happens to the district court ruling,” Bonauto said. “Does Edie get her money back, or is there an argument that the district court ruling goes away because the U.S. switched positions in the district court. I’d like to think, at a minimum, Edie would get her money back.”
Vicki Jackson, a Harvard law professor hired by the court, will argue BLAG doesn’t have standing in the lawsuit and the court doesn’t have jurisdiction to hear the case. Deputy Solicitor General Sri Srinavasan is set to address the standing issue on behalf of the Justice Department. BLAG also has been allocated time to assert it has standing in the case, but Windsor’s attorneys weren’t granted time to talk about jurisdiction or standing.
NCLR’s Stoll said any decision from justices that would extend rights to gay couples — whether on the merits or through issues of standing — would be a “milestone” for the LGBT community.
“We have already been seeing tremendous changes in society and the level of acceptance for gay and lesbian people and for legal recognition of them through marriage,” Stoll said. “I think that if the Supreme Court ruled in whatever way in favor of the plaintiffs in these cases, that it would be a real milestone and landmark moment for our movement.”
A Wider Bridge on Friday announced it will shut down at the end of the month.
The group that “mobilizes the LGBTQ community to fight antisemitism and support Israel and its LGBTQ community” in a letter to supporters said financial challenges prompted the decision.
“After 15 years of building bridges between LGBTQ communities in North America and Israel, A Wider Bridge has made the difficult decision to wind down operations as of Dec. 31, 2025,” it reads.
“This decision comes after challenging financial realities despite our best efforts to secure sustainable funding. We deeply appreciate our supporters and partners who made this work possible.”
Arthur Slepian founded A Wider Bridge in 2010.
The organization in 2016 organized a reception at the National LGBTQ Task Force’s Creating Change Conference in Chicago that was to have featured to Israeli activists. More than 200 people who protested against A Wider Bridge forced the event’s cancellation.
A Wider Bridge in 2024 urged the Capital Pride Alliance and other Pride organizers to ensure Jewish people can safely participate in their events in response to an increase in antisemitic attacks after Hamas militants attacked Israel on Oct. 7, 2023.
The Jewish Telegraphic Agency reported authorities in Vermont late last year charged Ethan Felson, who was A Wider Bridge’s then-executive director, with lewd and lascivious conduct after alleged sexual misconduct against a museum employee. Rabbi Denise Eger succeeded Felson as A Wider Bridge’s interim executive director.
A Wider Bridge in June honored U.S. Rep. Debbie Wasserman Schultz (D-Fla.) at its Pride event that took place at the Capital Jewish Museum in D.C. The event took place 15 days after a gunman killed two Israeli Embassy employees — Yaron Lischinsky and Sarah Milgrim — as they were leaving an event at the museum.
“Though we are winding down, this is not a time to back down. We recognize the deep importance of our mission and work amid attacks on Jewish people and LGBTQ people – and LGBTQ Jews at the intersection,” said A Wider Bridge in its letter. “Our board members remain committed to showing up in their individual capacities to represent queer Jews across diverse spaces — and we know our partners and supporters will continue to do the same.”
Editor’s note: Washington Blade International News Editor Michael K. Lavers traveled to Israel and Palestine with A Wider Bridge in 2016.
The White House
‘Trump Rx’ plan includes sharp cuts to HIV drug prices
President made announcement on Friday
President Donald Trump met with leaders from some of the world’s largest pharmaceutical companies at the White House on Friday to announce his new “Trump Rx” plan and outline efforts to reduce medication costs for Americans.
During the roughly 47-minute meeting in the Roosevelt Room, Trump detailed his administration’s efforts to cut prescription drug prices and make medications more affordable for U.S. patients.
“Starting next year, American drug prices will come down fast, furious, and will soon be among the lowest in the developed world,” Trump said during the meeting. “For decades, Americans have been forced to pay the highest prices in the world for prescription drugs by far … We will get the lowest price of anyone in the world.”
Trump signed an executive order in May directing his administration “to do everything in its power to slash prescription drug prices for Americans while getting other countries to pay more.”
“This represents the greatest victory for patient affordability in the history of American health care, by far, and every single American will benefit,” he added.
Several pharmaceutical executives stood behind the president during the announcement, including Sanofi CEO Paul Hudson, Novartis CEO Vas Narasimhan, Genentech CEO Ashley Magargee, Boehringer Ingelheim (USA) CEO Jean-Michel Boers, Gilead Sciences CEO Dan O’Day, Bristol Myers Squibb General Counsel Cari Gallman, GSK CEO Emma Walmsley, Merck CEO Robert Davis, and Amgen Executive Vice President Peter Griffith.
Also in attendance were Health and Human Services Secretary Robert F. Kennedy Jr., Commerce Secretary Howard Lutnick, Centers for Medicare and Medicaid Services Administrator Mehmet Oz, and Food and Drug Administration Commissioner Marty Makary.
Under the Trump Rx plan, the administration outlined a series of proposed drug price changes across multiple companies and therapeutic areas. Among them were reductions for Amgen’s cholesterol-lowering drug repatha from $573 to $239; Bristol Myers Squibb’s HIV medication reyataz from $1,449 to $217; Boehringer Ingelheim’s type 2 diabetes medication jentadueto from $525 to $55; Genentech’s flu medication xofluza from $168 to $50; and Gilead Sciences’ hepatitis C medication epclusa from $24,920 to $2,425.
Additional reductions included several GSK inhalers — such as the asthma inhaler advair diskus 500/50, from $265 to $89 — Merck’s diabetes medication januvia from $330 to $100, Novartis’ multiple sclerosis medication mayzent from $9,987 to $1,137, and Sanofi’s blood thinner plavix from $756 to $16. Sanofi insulin products would also be capped at $35 per month’s supply.
These prices, however, would only be available to patients who purchase medications directly through TrumpRx. According to the program’s website, TrumpRx “connects patients directly with the best prices, increasing transparency, and cutting out costly third-party markups.”
Kennedy spoke after Trump, thanking the president for efforts to lower pharmaceutical costs in the U.S., where evidence has shown that drug prices — including both brand-name and generic medications — are nearly 2.78 times higher than prices in comparable countries. According to the Pharmaceutical Research and Manufacturers of America, roughly half of every dollar spent on brand-name drugs goes to entities that play no role in their research, development, or manufacturing.
“This is affordability in action,” Kennedy said. “We are reversing that trend and making sure that Americans can afford to get the life-saving solutions.”
Gilead CEO Dan O’Day also spoke about how the restructuring of drug costs under TrumpRx, combined with emerging technologies, could help reduce HIV transmission — a virus that, if untreated, can progress to AIDS. The LGBTQ community remains disproportionately affected by HIV.
“Thank you, Mr. President — you and the administration,” O’Day said. “I think this objective of achieving the commitment to affordability and future innovation is extraordinary … We just recently launched a new medicine that’s only given twice a year to prevent HIV, and we’re working with Secretary Kennedy and his entire team, as well as the State Department, as a part of your strategy to support ending the epidemic during your term.
“I’ve never been more optimistic about the innovation that exists across these companies and the impact this could have on America’s health and economy,” he added.
Trump interjected, asking, “And that’s working well with HIV?”
“Yes,” O’Day replied.
“It’s a big event,” Trump said.
“It literally prevents HIV almost 100 percent given twice a year,” O’Day responded.
A similar anti-HIV medication is currently prescribed more than injectable form mentioned by O’Day. PrEP, is a medication regimen proven to significantly reduce HIV infection rates for people at high risk. Without insurance, brand-name Truvada can cost roughly $2,000 per month, while a generic version costs about $60 per month.
Even when medication prices are reduced, PrEP access carries additional costs, including clinic and laboratory fees, office visits, required HIV and sexually transmitted infection testing, adherence services and counseling, and outreach to potentially eligible patients and providers.
According to a 2022 study, the annual total cost per person for PrEP — including medication and required clinical and laboratory monitoring — is approximately $12,000 to $13,000 per year.
The TrumpRx federal platform website is now live at TrumpRx.gov, but the program is not slated to begin offering reduced drug prices until January.
The White House
EXCLUSIVE: Democracy Forward files FOIA lawsuit after HHS deadnames Rachel Levine
Trans former assistant health secretary’s name changed on official portrait
Democracy Forward, a national legal organization that works to advance democracy and social progress through litigation, policy and public education, and regulatory engagement, filed a lawsuit Friday in federal court seeking to compel the U.S. Department of Health and Human Services to release information related to the alteration of former Assistant Secretary for Health Adm. Rachel Levine’s official portrait caption.
The lawsuit comes in response to the slow pace of HHS’s handling of multiple Freedom of Information Act requests — requests that federal law requires agencies to respond to within 20 working days. While responses can take longer due to backlogs, high request volumes, or the need for extensive searches or consultations, Democracy Forward says HHS has failed to provide any substantive response.
Democracy Forward’s four unanswered FOIA requests, and the subsequent lawsuit against HHS, come days after someone in the Trump-Vance administration changed Levine’s official portrait in the Hubert H. Humphrey Building to display her deadname — the name she used before transitioning and has not used since 2011.
According to Democracy Forward, HHS “refused to release any records related to its morally wrong and offensive effort to alter former Assistant Secretary for Health Admiral Rachel Levine’s official portrait caption.” Levine was the highest-ranking openly transgender government official in U.S. history and served as assistant secretary for health and as an admiral in the U.S. Public Health Service Commissioned Corps from 2021 to 2025.
Democracy Forward President Skye Perryman spoke about the need to hold the Trump-Vance administration accountable for every official action, especially those that harm some of the most targeted Americans, including trans people.
“The question every American should be asking remains: what is the Trump-Vance administration hiding? For an administration that touts its anti-transgender animus and behavior so publicly, its stonewalling and silence when it comes to the people’s right to see public records about who was behind this decision is deafening,” Perryman said.
“The government’s obligation of transparency doesn’t disappear because the information sought relates to a trailblazing former federal official who is transgender. It’s not complicated — the public is entitled to know who is making decisions — especially decisions that seek to alter facts and reality, erase the identity of a person, and affect the nation’s commitment to civil rights and human dignity.”
“HHS’s refusal to respond to these lawful requests raises more serious concerns about transparency and accountability,” Perryman added. “The public has every right to demand answers — to know who is behind this hateful act — and we are going to court to get them.”
The lawsuit also raises questions about whether the alteration violated federal accuracy and privacy requirements governing Levine’s name, and whether the agency improperly classified the change as an “excepted activity” during a lapse in appropriations. By failing to make any determination or produce any records, Democracy Forward argues, HHS has violated its obligations under federal law.
The case, Democracy Forward Foundation v. U.S. Department of Health and Human Services, was filed in the U.S. District Court for the District of Columbia. The legal team includes Anisha Hindocha, Daniel McGrath, and Robin Thurston.
The Washington Blade reached out to HHS, but has not received any comment.
The lawsuit and four FOIA requests are below:
Long-awaited ‘Pillion’ surpasses the sexy buzz
Trump’s ‘American people derangement syndrome’
Reasons to be optimistic about 2026
Using movement to boost your mental health during holidays
Protecting the trans community is not optional for elected allies and candidates
Reasons to be optimistic about 2026
America is going in the wrong direction for intersex children
Rush reopens after renewing suspended liquor license
Child- and pet-proofing your home for the holidays
Few transgender people benefit from India’s low-income housing program
-
District of Columbia1 day agoReasons to be optimistic about 2026
-
Commentary3 days ago
America is going in the wrong direction for intersex children
-
District of Columbia3 days ago
Rush reopens after renewing suspended liquor license
-
Real Estate4 days ago
Child- and pet-proofing your home for the holidays
